COMPARATIVE EVALUATION OF IMMUNOGENICITY AND REACTOGENICITY OF BIVALENT ORAL POLIOVIRUS VACCINE (bOPV from Sanofi Pasteur bulk) VERSUS PRE QUALIFIED BIVALENT ORAL POLIOVIRUS VACCINE (bOPV from PT BioFarma bulk): A RANDOMIZED DOUBLE-BLIND TRIAL.
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2016
At a glance
- Drugs Poliovirus vaccine live oral (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 19 Jan 2011 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
- 30 Jul 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India record.
- 27 Jul 2010 New trial record